arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Xilio Therapeutics, Inc.

XLO Health Care Biotechnology: Pharmaceutical Preparations
$7.90
▼ -6.3% Today
as of Oct 23, 13:52 ET
Last 30 days -11.53% Sep 14 → Oct 23
$7.79 $8.18 $8.56 $8.94 $9.33 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$8.45
High
$8.48
Low
$8.00
Volume
$13,757
Avg Vol
$36,454
Mkt Cap
$59M
P/E (TTM)
—
Beta
—
52w High
$12.59
52w Low
$6.47
Div Yield
—
Shares Out
$7M

Recent Press Releases & News last 60 days · 3 items

XLO earnings at a glance

Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.0% on average; after the most recent report on May 12, 2026 it moved +0.0%. XLO beat the consensus EPS estimate in 1 of its last 4 reported quarters. The share price of $7.90 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$6.47
$13
23% of range
Avg surprise (last 4)
-92.0%
Avg reaction (last 2)
+4.0%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.83$-0.60$-0.36$-0.13$0.10 Actual $-0.83Actual $-0.70Actual $-0.61Actual $-0.62Actual $-0.24Actual $-0.22Actual $-0.18Est $0.10Actual $-0.16Est $-0.08Actual $-0.03Est $-0.03Actual $-0.58Est $-0.66Actual $-0.33 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-16M$-7M$2M$11M$20M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.33 — — — — financials
Tue May 12, 2026Mar/2026 $-0.58 $-0.66 +12.1% -222.2% 0.0% earnings
Thu Nov 13, 2025Sep/2025 $-0.03 $-0.03 0.0% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.16 $-0.08 -100.0% — — earnings
Thu May 8, 2025Mar/2025 $-0.18 $0.10 -280.0% — +7.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.22 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.24 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.62 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.61 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.70 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.83 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$19M$13M—$19M$8M$3M—$2M
Cost of revenue————————
Gross profit————————
Operating income$-3M$-14M—$-2M$-14M$-14M—$-15M
Net income$-6M$-10M—$-16M$-16M$-13M—$-14M
EPS (diluted)$-0.33$-0.58—$-0.11$-2.30$-2.49—$-0.22

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$136M$150M$138M$104M$122M$89M$55M$61M
Inventory————————
Total current assets$145M$154M$145M$124M$124M$93M$60M$63M
Total assets$154M$163M$155M$134M$134M$104M$71M$75M
Long-term debt————————
Total liabilities$82M$91M$119M$142M$127M$93M$53M$54M
Total equity$72M$73M$35M$-8M$7M$11M$18M$21M

Implied volatility — last 90 days

No IV snapshots yet for XLO.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

XLO earnings FAQ

How does XLO stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.0%, up 1 times and down 1 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.